LB-001

DB17685ExperimentalGene Therapies

LB-001 is a gene editing therapy designed to incorporate a functioning version of the faulty methylmalonyl-COA mutase (MUT) gene into the genome of patients with methylmalonic acidemia.

Code names
LB-001

Which companies are running trials of LB-001, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.

Create Account